Cutanix distribution
This article was originally published in The Rose Sheet
Executive Summary
Copper peptide technology manufacturer ProCyte will market Cutanix Dramatic Relief product line to 3,000 physicians under exclusive distribution agreement, Redmond, Wash. firm announces. Two-year deal covers distribution rights for the medical and spa markets for all current and future Cutanix products formulated with Quadrinone. Patent-pending technology reduces inflammation associated with conditions such as rosacea and eczema, according to the company. Introduced in June 2002, Cutanix Dramatic Relief products include lotions for dry to normal skin, sensitive facial skin and oily and acne-prone skin, which retail for $45. Cutanix will launch Dramatic Relief body lotion, extra strength lotion and intensified eye serum in October...